Consultant Medical Oncologist

Dr. Rafael Bach

The Clatterbridge Cancer Centre · Private Consultations Available

Specialising in melanoma, skin cancer and immunotherapy

Melanoma & Skin Cancer Immunotherapy Clinical Trials Targeted Therapy
Book a Private Consultation Learn More
Scroll
About
Dr. Rafael Bach

About Dr. Bach

Dr. Rafael Bach is a Consultant Medical Oncologist at The Clatterbridge Cancer Centre, specialising in the management of melanoma and skin cancer. He completed his medical degree in Málaga and his specialist training in Barcelona, followed by a visiting fellowship at Clatterbridge before his appointment as a Consultant.

Dr. Bach is a member of the Specialist Immunotherapy Toxicity Service (SIOTS), where he focuses on improving patient safety and the management of treatment-related side effects. His clinical work is complemented by his involvement in research, serving as sub-investigator and principal investigator for international clinical trials.

He is also contributing to the development of advanced cell therapies, including Tumour-Infiltrating Lymphocyte (TIL) therapy, at one of the UK's leading cancer centres.

Royal College of Physicians ASCO ESMO
Areas of Expertise

Clinical Specialisms

🔬
Melanoma & Skin Cancer

Comprehensive management of systemic treatment for cutaneous melanoma and other skin malignancies, from adjuvant therapy post-surgery through to advanced disease.

💉
Immunotherapy

Expert in checkpoint inhibitor therapies, combination immunotherapy strategies, and management of immune-related adverse events.

🧬
Targeted Therapy

Specialist in molecularly targeted treatments, including BRAF-targeted therapy for BRAF-mutated melanoma and Vismodegib for advanced Basal Cell Carcinoma.

🛡️
Toxicity Management

Member of the Specialist Immunotherapy Toxicity Service, focused on patient safety and optimising treatment outcomes.

📋
Clinical Trials

Active investigator in international phase II–III clinical trials, connecting patients with innovative therapies.

☢️
Combined Modality Treatment

Delivering integrated treatment approaches combining systemic therapy with radiotherapy, working alongside our expert clinical oncology and radiotherapy team.

Research

Selected Publications

OncoImmunology · 2025
Molecular and immunological features associated with long-term benefits in metastatic NSCLC patients undergoing immune checkpoint blockade
Rocha P, Bach R, et al. — OncoImmunology, Vol. 14, No. 1
Cancers (MDPI) · 2025
MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer
Li H, Hong L, Rocha P, Bach R, et al. — Cancers 2025, 17(23), 3801
The Lancet Regional Health – Europe · 2024
Development of a prognostic model to predict 90-day mortality in hospitalised cancer patients (PROMISE tool): a prospective observational study
Bach R among authors — The Lancet Regional Health – Europe, 2024
Cancer Research · AACR Annual Meeting 2024
Abstract 6391: Spatial proteomic profiling unveils pre-existing immunity features associated with long-term immunotherapy benefit
Bach R among authors — Cancer Research (2024), 84(6 Supplement)
Clinical Trials

Active Research at Clatterbridge

IGNYTE-3
Replimune

An international clinical trial investigating novel oncolytic immunotherapy approaches in melanoma. Dr. Bach is serving as Principal Investigator at The Clatterbridge Cancer Centre, offering eligible patients access to this cutting-edge treatment.

Role: Principal Investigator — The Clatterbridge Cancer Centre
Active
View all melanoma research studies at Clatterbridge →
Private Consultations

Book an Appointment

Dr. Bach offers private consultations for patients seeking specialist expertise in melanoma, skin cancer, and immunotherapy. Whether you are looking for a second opinion, a diagnostic review, or ongoing private care, Dr. Bach is available through the Clatterbridge Private service.

Contact for a Private Consultation

The Clatterbridge Cancer Centre · Wirral & Liverpool